Impact of Point-Spread Function Reconstruction on 68Ga-DOTATATE PET/CT Quantitative Imaging Parameters

被引:3
|
作者
You, Helena [1 ]
Sanli, Yasemin [1 ]
Subramaniam, Rathan M. [1 ,2 ,3 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
关键词
Ga-68-DOTATATE; neuroendocrine tumors; PET/CT; point-spread function; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; TIME-OF-FLIGHT; NEUROENDOCRINE TUMORS; F-18-FDG PET/CT; MANAGEMENT; HETEROGENEITY; DIAGNOSIS; IN-111-DTPA-OCTREOTIDE; DOSIMETRY;
D O I
10.2214/AJR.18.21067
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to investigate the impact of point-spread function (PSI) reconstruction and lesion size on Ga-68-tetraazacyclododecanetetraacetic acid-DPhel-Tyr3-octreotate (DOTATATE) PET/CT quantitative parameters. MATERIALS AND METHODS. A total of 38 patients with 42 Ga-68-DOATATE PET/CT studies and 125 lesions were included. Scans were reconstructed with and without PSF modulation. For each lesion, the maximum standardized uptake value (SUVmax) and peak standardized uptake value (SUVpeak), metabolic tumor volume (MTV), total lesion somatostatin avidity, and tumor somatostatin receptor expression heterogeneity using the AUC method were measured. Intraclass correlation coefficient (ICC) and Bland-Altman analyses were used to compare PSF and non-PSF values. A subgroup analysis was performed to determine the impact of lesion size. RESULTS. Of the 125 lesions, 51 were in the liver, 31 in lymph nodes, 17 in bone, eight in pancreas, four in lung, and 14 in other sites. The ICCs between PSF and non-PSF values were excellent for SUVmax, SUVpeak, MTV, and total lesion somatostatin avidity (ICC = 0.97-0.99), and the ICC was good for tumor somatostatin receptor expression heterogeneity (ICC = 0.81). Comparison of PSF with non-PSF values showed a bias (mean percentage change +/- SD) of 27.5% +/- 14.7% for SUVmax, 15.5% +/- 9.5% for SUVpeak, -18.6% +/- 37.6% for MTV, 0.8% +/- 28.1% for total lesion somatostatin avidity, and -7.1% +/- 11.0% for tumor somatostatin receptor expression heterogeneity. Comparison of PSF with non-PSF values for lesions less than 2 cm (n = 75) showed corresponding biases greater than those for lesions 2 cm or larger (n = 50). CONCLUSION. PSF reconstruction effected higher values for SUVmax and SUVpeak, produced decreased values for tumor somatostatin receptor expression heterogeneity, and had a variable effect on MTV and total lesion somatostatin avidity depending on lesion size.
引用
收藏
页码:683 / 688
页数:6
相关论文
共 50 条
  • [1] Impact of Point-Spread Function Reconstruction on Dynamic and Static FDOPA PET/CT Quantitative Parameters in Glioma
    Girard, A.
    Madani, F.
    Chaboub, N.
    Le Reste, P.
    Devillers, A.
    Saint-Jalmes, H.
    Le Jeune, F.
    Palard-Novello, X.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S238 - S239
  • [2] 68Ga-DOTATATE PET–CT imaging in carotid body paragangliomas
    Duygu Has Şimşek
    Yasemin Şanlı
    Serkan Kuyumcu
    Bora Başaran
    Ayşe Mudun
    Annals of Nuclear Medicine, 2018, 32 : 297 - 301
  • [3] 68Ga-DOTATATE PET/CT Imaging in Carotid Body Tumor
    Gayana, Shankaramurthy
    Mittal, Bhagwant Rai
    Bhattacharya, Anish
    Radotra, Bishan Dass
    Gupta, Ashok K.
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (04) : E191 - E193
  • [4] Impact of Point Spread Function (PSF) reconstruction on 68Ga-DOTATOC PET/CT Quantitative Imaging Parameters a patient and phantom pilot study
    McCann, A.
    Liddy, S.
    Maguire, D.
    Loughman, E.
    Dowling, A.
    Harris, L.
    Vintro, L. L.
    Cournane, S.
    Lucey, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S417 - S417
  • [5] Evaluation of SUL measurements in 68Ga-DOTATATE PET/ CT Imaging
    Parlak, Y.
    Mutevelizade, G.
    Goksoy, D.
    Gumuser, G.
    Sayit, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S602 - S602
  • [6] Role of 68Ga-DOTATATE PET/CT Quantitative Parameters in the Differential Diagnosis of Adrenal Lesions
    Denizmen, D.
    Simsek, D. Has
    Isik, E. G.
    Hacisahinogullari, H.
    Kuyumcu, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S299 - S299
  • [7] Management Impact of 68Ga-DOTATATE PET/CT in Neuroendocrine Tumors
    Anderson, Redmond-Craig
    Velez, Erik M.
    Desai, Bhushan
    Jadvar, Hossein
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 55 (01) : 31 - 37
  • [8] Management Impact of 68Ga-DOTATATE PET/CT in Neuroendocrine Tumors
    Redmond-Craig Anderson
    Erik M. Velez
    Bhushan Desai
    Hossein Jadvar
    Nuclear Medicine and Molecular Imaging, 2021, 55 : 31 - 37
  • [9] Incidental 68Ga-DOTATATE Uptake on PET/CT
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 22N - 22N
  • [10] Osteoporosis Circumscripta on 68Ga-DOTATATE PET CT
    Gandy, Nemi
    Ordidge, Katherine Louise
    Arshad, Mubarik
    Win, Zarni
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E404 - E405